Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy

Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy

Cancer cells express tumour-specific antigens derived via genetic and epigenetic alterations, which may be targeted by T-cell-mediated immune responses. However, cancer cells can avoid immune surveillance by suppressing immunity through activation of specific inhibitory signalling pathways, referred...

Full description

Bibliographic Details
Main Authors: Lee, Ju Yeon, Lee, Hyun Tae, Shin, Woori, Chae, Jongseok, Choi, Jaemo, Kim, Sung Hyun, Lim, Heejin, Won Heo, Tae, Park, Kyeong Young, Lee, Yeon Ji, Ryu, Seong Eon, Son, Ji Young, Lee, Jee Un, Heo, Yong-Seok
Format: Online
Language:English
Published: Nature Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095608/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095608/

Similar Items